Depression in Alzheimer’s disease

References

• Payne JL, Sheppard JM, Steinberg M, Warren A, Baker A, Steele C. Incidence, prevalence, and outcomes of depression in residents of a long-term care facility with dementia. Int. J. Geriatr. Psychiatry17(3), 247–253 (2002).
   PubMed Web of Science ®Google Scholar
• Cummings JL. The impact of depressive symptoms on patients with Alzheimer disease. Alzheimer. Dis. Assoc. Disord.17, 61–62 (2003).
   PubMed Web of Science ®Google Scholar
• Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA288(12), 1475–1483 (2002).
   PubMed Web of Science ®Google Scholar
• Lee HB, Lyketsos CG. Depression in Alzheimer's disease: heterogeneity and related issues. Biol. Psych.54(3), 353–362 (2003).
   PubMed Web of Science ®Google Scholar
• Kales HC, Chen P, Blow FC, Welsh DE, Mellow AM. Rates of clinical depression diagnosis, functional impairment, and nursing home placement in coexisting dementia and depression. Am. J. Geriatr. Psychiatry13, 441–449 (2005).
   PubMed Web of Science ®Google Scholar
• Cohen CI, Hyland K, Kimhy D. The utility of mandatory depression screening of dementia patients in nursing homes. Am. J. Psych.160, 2012–2017 (2003).
   PubMed Web of Science ®Google Scholar
• Lyketsos CG, Olin J. Depression in Alzheimer’s disease: overview and treatment. Biol. Psych.52(3), 243–252 (2002).
   PubMed Web of Science ®Google Scholar
• Gallo JJ, Rabins PV, Anthony JC. Sadness in older persons: 13-year follow-up of a community sample in Baltimore, Maryland. Psychol. Med.29(2), 341–350 (1999).
   PubMed Web of Science ®Google Scholar
• Gallo JJ, Rabins PV, Lyketsos CG, Tien AY, Anthony JC. Depression without sadness: functional outcomes of nondysphoric depression in later life. J. Am. Geriatr. Soc.45(5), 570–578 (1997).
   PubMed Web of Science ®Google Scholar
• Olin JT, Katz IR, Meyers BS, Schneider LS, Lebowitz BD. Provisional diagnostic criteria for depression of Alzheimer disease: rationale and background. Am. J. Geriatr. Psychiatry10(2), 129–141 (2002).
   PubMed Web of Science ®Google Scholar
• Chemerinski E, Petracca G, Sabe L, Kremer J, Starkstein SE. The specificity of depressive symptoms in patients with Alzheimer’s disease. Am. J. Psych.158(1), 68–72 (2001).
   PubMed Web of Science ®Google Scholar
• Loewenstein DA, Arguelles S, Bravo M, Freeman RQ, Arguelles T, Acevedo A. Caregivers’ judgments of the functional abilities of the Alzheimer’s disease patient: a comparison of proxy reports and objective measures. J. Gerontol. B. Psychol. Sci. Soc. Sci.56(2), P78–P84 (2001).
   PubMed Web of Science ®Google Scholar
• Teri L, Truax P. Assessment of depression in dementia patients: association of caregiver mood with depression ratings. Gerontologist34(2), 231–234 (1994).
   PubMed Web of Science ®Google Scholar
• Rosenberg PB, Mielke MM, Lyketsos CG. Caregiver assessment of patients’ depression in Alzheimer disease: longitudinal analysis in a drug treatment study. Am. J. Geriatr. Psychiatry13, 822–826 (2005).
   PubMed Web of Science ®Google Scholar
• Li YS, Meyer JS, Thornby J. Longitudinal follow-up of depressive symptoms among normal versus cognitively impaired elderly. Int. J. Geriatr. Psychiatry16(7), 718–727 (2001).
   PubMed Web of Science ®Google Scholar
• Zubenko GS, Zubenko WN, McPherson S, Spoor E, Marin DB, Farlow MR. A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer’s disease. Am. J. Psych.160, 857–866 (2003).
   PubMed Web of Science ®Google Scholar
• Lyketsos CG, Lee HB. Diagnosis and treatment of depression in Alzheimer's disease. A practical update for the clinician. Dement. Geriatr. Cogn. Disord.17(1–2), 55–64 (2004).
   Google Scholar
• Lyketsos CG, Sheppard JM, Steinberg M, Tschanz JA, Norton MC, Steffens DC. Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: the Cache County study. Int. J. Geriatr. Psychiatry16(11), 1043–1053 (2001).
   PubMed Web of Science ®Google Scholar
• Rosenberg PB, Onyike CU, Katz IR, Porsteinsson AP, Mintzer JE, Schneider LS. Clinical application of operationalized criteria for ‘depression of Alzheimer’s disease’. Int. J. Geriatr. Psychiatry20(2), 119–127 (2005).
   PubMed Web of Science ®Google Scholar
• Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. ‘Vascular depression’ hypothesis. Arch. Gen. Psych.54(10), 915–922 (1997).
   PubMed Web of Science ®Google Scholar
• Geda YE, Knopman DS, Mrazek DA. Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a propsective cohort study. Arch. Neurol.63, 435–440 (2006).
   PubMed Web of Science ®Google Scholar
• Jorm AF. History of depression as a risk factor for dementia: an updated review. Aust. NZJ Psychiatry35(6), 776–781 (2001).
   PubMed Web of Science ®Google Scholar
• Olin JT, Schneider LS, Katz IR, Meyers BS, Alexopoulos GS, Breitner JC. Provisional diagnostic criteria for depression of Alzheimer disease. Am. J. Geriatr. Psychiatry10(2), 125–128 (2002).
   PubMed Web of Science ®Google Scholar
• Starkstein SE, Mizrahi R, Garau LM. Specificity of symptoms of depression in Alzheimer disease: a longitudinal analysis. Am. J. Geriatr. Psychiatry13, 803–807 (2005).
   Google Scholar
• Starkstein SE, Jorge R, Mizrahi R, Robinson RG. The construct of minor and major depression in Alzheimer’s disease. Am. J. Psych.162, 2086–2093 (2005).
   PubMed Web of Science ®Google Scholar
• Migliorelli R, Teson A, Sabe L, Petrachi M, Leiguarda R, Starkstein SE. Prevalence and correlates of dysthymia and major depression among patients with Alzheimer’s disease. Am. J. Psych.152, 37–44 (1995).
   PubMed Web of Science ®Google Scholar
• Lyketsos CG, Steinberg M, Tschanz JT, Norton MC, Steffens DC, Breitner JC. Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am. J. Psych.157(5), 708–714 (2000).
   PubMed Web of Science ®Google Scholar
• Steinberg M, Munro CA, Samus Q, Brandt J, Lyketsos CG. Patient predictors of response to treatment of depression in Alzheimer’s disease: the DIADS study. Int. J. Geriatr. Psychiatry19(2), 144–150 (2004).
   Google Scholar
• Burns A, Jacoby R, Levy R. Psychiatric phenomena in Alzheimer’s disease III: disorders of mood. Br. J. Psych.157, 81–86 (1990).
   PubMed Web of Science ®Google Scholar
• Aalten P, de Vugt ME, Jaspers N, Jolles J, Verhey FR. The course of neuropsychiatric symptoms in dementia. Part I: findings from the two-year longitudinal Maasbed study. Int. J. Geriatr. Psychiatry20(6), 523–530 (2005).
   PubMed Web of Science ®Google Scholar
• Aalten P, de Vugt ME, Jaspers N, Jolles J, Verhey FR. The course of neuropsychiatric symptoms in dementia. Part II: relationships among behavioural sub-syndromes and the influence of clinical variables. Int. J. Geriatr. Psychiatry20(6), 531–536 (2005).
   PubMed Web of Science ®Google Scholar
• Starkstein SE, Chemerinski E, Sabe L, Kuzis G, Petracca G, Teson A. Prospective longitudinal study of depression and anosognosia in Alzheimer’s disease. Br. J. Psych.171, 47–52 (1997).
   PubMed Web of Science ®Google Scholar
• Garre-Olmo J, Lopez-Pousa S, Vilalta-Franch J, Turon-Estrada A, Hernandez-Ferrandiz M, Lozano-Gallego M. Evolution of depressive symptoms in Alzheimer disease: one-year follow-up. Alzheimer. Dis. Assoc. Disord.17(2), 77–85 (2003).
   PubMed Web of Science ®Google Scholar
• Reifler BV, Teri L, Raskind M, Veith R, Barnes R, White E. Double-blind trial of imipramine in Alzheimer’s disease patients with and without depression. Am. J. Psych.146(1), 45–49 (1989).
   PubMed Web of Science ®Google Scholar
• Fuchs A, Hehnke U, Erhart C, Schell C, Pramshohler B, Danninger B. Video rating analysis of effect of maprotiline in patients with dementia and depression. J. Psychopharmacol ogy26(2), 37–41 (1993).
   Google Scholar
• Petracca G, Teson A, Chemerinski E, Leiguarda R, Starkstein SE. A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer’s disease. J. Neuropsych. Clin. Neurosci.8(3), 270–275 (1996).
   PubMed Web of Science ®Google Scholar
• Nyth AL, Gottfries CG. The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study. Br. J. Psych.157, 894–901 (1990).
   PubMed Web of Science ®Google Scholar
• Nyth AL, Gottfries CG, Lyby K, Smedegaard-Andersen L, Gylding-Sabroe J, Kristensen M. A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia. Acta Psychiatrica. Scandinavica86(2), 138–145 (1992).
   PubMed Web of Science ®Google Scholar
• Petracca GM, Chemerinski E, Starkstein SE. A double-blind, placebo-controlled study of fluoxetine in depressed patients with Alzheimer’s disease. Int. Psychogeriatrics13(2), 233–240 (2001).
   PubMed Web of Science ®Google Scholar
• Lyketsos CG, Sheppard JM, Steele CD, Kopunek S, Steinberg M, Baker AS. Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: initial results from the Depression in Alzheimer’s Disease study. Am. J. Psych.157(10), 1686–1689 (2000).
   PubMed Web of Science ®Google Scholar
• Magai C, Kennedy G, Cohen CI, Gomberg D. A controlled clinical trial of sertraline in the treatment of depression in nursing home patients with late-stage Alzheimer’s disease. Am. J. Geriatr. Psychiatry8(1), 66–74 (2000).
   PubMed Web of Science ®Google Scholar
• Taragano FE, Lyketsos CG, Mangone CA, Allegri RF, Comesana-Diaz E. A double-blind, randomized, fixed-dose trial of fluoxetine vs. amitriptyline in the treatment of major depression complicating Alzheimer’s disease. Psychosomatics38(3), 246–252 (1997).
   PubMed Web of Science ®Google Scholar
• Katona CL, Hunter BN, Bray J. A double-blind comparison of the efficacy and safely of paroxetine and imipramine in the treatment of depression with dementia. Int. J. Geriatr. Psychiatry13(2), 100–108 (1998).
   PubMed Web of Science ®Google Scholar
• Lyketsos CG, DelCampo L, Steinberg M, Miles Q, Steele CD, Munro C. Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS. Arch. Gen. Psych.60(7), 737–746 (2003).
   PubMed Web of Science ®Google Scholar
• Roth M, Mountjoy CQ, Amrein R. Moclobemide in elderly patients with cognitive decline and depression: an international double-blind, placebo-controlled trial. Br. J. Psych.168(2), 149–157 (1996).
   PubMed Web of Science ®Google Scholar
• Teri L, Logsdon RG, Uomoto J, McCurry SM. Behavioral treatment of depression in dementia patients: a controlled clinical trial. J. Gerontol. B Psychol. Sci. Soc. Sci.52(4), P159–P166 (1997).
   PubMed Web of Science ®Google Scholar
• Livingston G, Johnston K, Katona CL, Paton J, Lyketsos CG. Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia. Am. J. Psych.162, 1996–2021 (2005).
   PubMed Web of Science ®Google Scholar
• Nelson J, Rosenberg D. ECT treatment of demented elderly patients with major depression: a retrospective study of efficacy and safety. Convulsive Therapy7, 157–165 (1991).
   Google Scholar
• Rao V, Lyketsos CG. The benefits and risks of ECT for patients with primary dementia who also suffer from depression. Int. J. Geriatr. Psychiatry15(8), 729–735 (2000).
   PubMedGoogle Scholar